CRISPR catches out critical cancer changes: New drug target for multiple cancers

In the first large-scale analysis of cancer gene fusions, researchers used CRISPR to uncover which gene fusions are critical for the growth of cancer cells. The team also identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian cancers. The results give more certainty for the use of specific gene fusions to diagnose and guide the treatment of patients.
Source: Science Daily,